Tooth Regrowth Drug: Japanese Trial Could Replace Implants

 The average adult human body is made up of 206 bones, formed from a strong combination of calcium, minerals, and collagen. These bones act as a natural support system, enabling us to move, work, and live our daily lives. What’s remarkable is that bones can heal and grow back if broken.

Teeth, however, are different. Although they are the hardest substance in the human body—thanks to their protective enamel—they cannot naturally regrow once damaged or lost. But this may soon change, as Japanese scientists are working on a revolutionary drug that could allow teeth to regrow naturally in humans.

The Beginning of Human Trials

In September 2024, researchers at Kitano Hospital Medical Research Institute in Osaka, led by Dr. Katsu Takahashi, began clinical trials on a new drug aimed at regenerating teeth. The project follows years of study on a specific protein called Uterine Sensitization-Associated Gene-1 (USAG-1), which is known to suppress tooth growth.

In earlier experiments, scientists discovered that blocking USAG-1 with a monoclonal antibody—a type of antibody typically used in cancer treatments—prevented it from binding to bone morphogenetic protein (BMP), a molecule crucial for the growth of bones and teeth. This breakthrough led to the successful regrowth of teeth in ferrets and mice after just a single dose.

Why Ferrets?

Ferrets were chosen for the research because their dental structure is very similar to that of humans, making them an ideal test subject for early experiments.

The Ongoing Human Study

The human trial currently involves 30 men aged 30 to 64, each missing at least one tooth. Over an 11-month period, the drug is being administered intravenously to assess its safety and effectiveness. Notably, in previous animal studies, no side effects were reported, which adds to the optimism surrounding the project.

If the treatment proves successful in adults, the next step will be to trial it on children aged 2 to 7 who have lost at least four teeth.

A Look Toward the Future

The ultimate goal is to make this drug available to the public by 2030. While the initial focus is on people with congenital tooth loss, researchers believe the treatment could eventually benefit anyone who has lost a tooth, potentially replacing the need for dental implants with a natural solution.

This groundbreaking research could transform dentistry forever, offering people the chance to regrow lost teeth—something once thought impossible.